Article Details

Myovant and Pfizer's uterine fibroids med scores FDA nod, setting up showdown with AbbVie

Retrieved on: 2021-05-26 22:18:45

Tags for this article:

Click the tags to see associated articles and topics

Myovant and Pfizer's uterine fibroids med scores FDA nod, setting up showdown with AbbVie. View article details on hiswai:

Excerpt

Pfizer will help Myovant sell Myfembree for uterine fibroid patients in the U.S. as early as June. The pharma giant doled out $650 million upfront plus ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up